The Department of Radiation Oncology at Beth Israel Deaconess Medical Center (BIDMC) in Boston is actively seeking applicants for a 1 year, full time, non-ACGME accredited CyberKnife stereotactic radiation fellowship. This program is designed to provide an understanding of the technical application as well as clinical management of stereotactic radiation, specifically using the CyberKnife platform. BIDMC has a well-established CyberKnife program with expertise in treatment of a wide range of conditions including lung cancer, CNS tumors, prostate cancer, metastatic disease, GI malignancies, and other abdominal/pelvic tumors. The fellow will primarily be at the main Boston location and will assist in the consultation, on treatment management, and follow up of patients undergoing CyberKnife radiation. They will be expected to attend and actively participate in multidisciplinary clinics, tumor boards, and didactic sessions. Although this is primarily a clinical fellowship, there is an expectation for participation in a mentored research project, which will be tailored to the individual fellow’s interest.
The applicant will be expected to meet the following requirements for employment
Completion of a radiation oncology residency
Be eligible for a Massachusetts Medical License and able to obtain one by the start date (tentatively July 1, 2021)
ABR certification/eligibility in Radiation Oncology or an equivalent board
MA Controlled Substance Registration
Individual Federal DEA
Interested candidates are invited to apply with a letter of interest, CV, and three references (or reference letters) to Danielle Bolea: firstname.lastname@example.org
Internal Number: 09242020
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center (BIDMC) is the flagship academic medical center of Beth Israel Lahey Health (BILH), a health care system consisting of 12 tertiary, specialty and community hospitals in Eastern Massachusetts. The Department of Radiation Oncology at the Beth Israel Deaconess Medical Center, affiliated with Harvard Medical School and Dana-Farber/Harvard Cancer Center, offers state of the art treatments involving a vast array of technologies and a large team of health care experts. Our department includes 3 True Beam Linear accelerators, a CyberKnife, an HDR afterloader, and a dedicated CT simulator. We have multiple active clinical trials as well as faculty participating in both translational and basic science research. Our faculty provides care at the BIDMC campus as well as four community sites located in Newburyport, Winchester, Framingham and Needham, MA.
HMFP/APHMFP offers equal employment opportunity to all applicants for employment and to all employees regardless of race, color, religion, sex, gender identity or expression, national origin, age, citizenship, sexual orientation, ancestry, marital status, pregnancy, physical or mental disability, medical condition, protected veteran status, or any other characteristic protected by applicable law.